What: Clinical data analysis experts from Novartis, Astra-Zeneca and Roche will present real-world examples of how they're driving shorter development cycles and fast, safe product approvals by using analytics to easily access, monitor and understand clinical data. This 90-minute complimentary Webcast, hosted by TIBCO Spotfire (
-- Inform early-stage trial design and dose selection with interactive
analysis of multivariate clinical data
-- Understand and assess drug safety data during clinical pharmacology
studies through instream medical monitoring
-- Provide safety assessment in pre-clinical and clinical studies through
exploratory analysis
When: Wednesday, April 22, 2009 at 10:00 a.m. ET.
Session Details:
-- Exploratory Data Analysis in Preclinical and Clinical
Safety
Presented by: Dr. Michael Merz, Novartis
-- Maximizing Safety in Clinical Pharmacology Unit Studies
Presented by: Ian Taylor and Paula Johansson, Astra-Zeneca
-- Use of Spotfire in Early/Exploratory Drug Development
Presented by: Michaela Jahn and Dr. Xavier Liogier D'ardhuy, Roche
Webcast Information: To register for this Webcast, go to:
http://goto.spotfire.com/g/?EJPERK7S9U=clicksrc:pr
About TIBCO
TIBCO Software Inc. (Contact Information: Media Inquiries Amy Groden-Morrison TIBCO Software Inc. 617-702-1710 http://spotfire.tibco.com Jim Baptiste Davies Murphy Group 781-418-2438 http://daviesmurphy.com